The North America healthcare cold chain logistics market reached a value of US$ 3.30 Billion in 2018. Healthcare cold chain refers to the system employed for protection of heat-liable biological preparations from deterioration by providing a temperature-controlled environment. The cold chain includes refrigerated storage, packaging, transportation and instrumentation of the healthcare products. It helps in maintaining integrity, efficacy and shelf life of products such as vaccines, biopharmaceuticals and clinical trial materials namely drugs, blood samples and tissue samples.
North America is one of the global leaders in the healthcare cold chain logistics market owing to the rising lifestyle diseases which has escalated the usage of distinctive cold chain products. Developed healthcare sector of the region has introduced automation for products, thus eliminating the scope of human handling errors in the cold chain. Apart from this, numerous cold chain logistics and transportation providers namely AmerisourceBergen and FedEx, have accelerated market growth in the region. Rapid technological innovations and rising consumer awareness towards the healthcare cold chain products will continue to spur the demand in the upcoming years. Looking forward, IMARC Group expects the market to reach a value of US$ 4.16 Billion by 2024, registering a CAGR of nearly 4% during 2019-2024.
Key Questions Answered in This Report:
Report Customization: Although IMARC has tried to cover everything in the North America healthcare cold chain logistics market landscape, we believe that every stakeholder may have their own specific needs. In view of this, we provide up to 20-man hours of free customization for each report.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-702-409-7331 )
( India: +91-120-433-0800 )
Drop us an email at